|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 92 No. 3 (August 1), 1998:
pp. 1011-1019
The Molecular and Phenotypic Profile of Primary Central Nervous
System Lymphoma Identifies Distinct Categories of the Disease and Is
Consistent With Histogenetic Derivation From Germinal
Center-Related B Cells
Luigi Maria Larocca,
Daniela Capello,
Alessandro Rinelli,
Simonetta Nori,
Andrea Antinori,
Annunziata Gloghini,
Antonella Cingolani,
Anna Migliazza,
Giuseppe Saglio,
Sophie Cammilleri-Broet,
Martine Raphael,
Antonino Carbone, and
Gianluca Gaidano
From the Institute of Pathology, Catholic University of the Sacred
Heart, Rome; Division of Internal Medicine, Department of Medical
Sciences, University of Torino at Novara, Novara; Institute of
Infectious Diseases, Catholic University of the Sacred Heart, Rome;
Division of Pathology, INRCCS-Centro di Riferimento Oncologico, Aviano;
Department of Clinical and Biological Sciences, University of Torino,
Orbassano-Torino, Italy; Division of Oncology, Department of Pathology,
College of Physicians & Surgeons, Columbia University, New York, NY;
Laboratoire de Neuropathologie, Pitié Salpètrière,
Paris; Service d'Hematologie Biologique, Hopital Avicenne, Bobigny,
Universitè de Paris XIII, Paris, France.
Primary central nervous system lymphoma (PCNSL) is a major cause of
morbidity and mortality among human immunodeficiency virus (HIV)-infected individuals. The precise histogenetic derivation and the
molecular pathogenesis of PCNSL is poorly understood. In an attempt to
clarify the histogenesis and pathogenesis of these lymphomas, 49 PCNSL
(26 acquired immunodeficiency syndrome [AIDS]-related and 23 AIDS-unrelated) were analyzed for multiple biologic markers, which are
known to bear histogenetic and pathogenetic significance for mature
B-cell neoplasms. PCNSL associated frequently (50.0%) with mutations
of BCL-6 5 noncoding regions, which are regarded as a
marker of B-cell transition through the germinal center (GC).
Expression of BCL-6 protein, which is restricted to GC B cells
throughout physiologic B-cell maturation, was detected in 100%
AIDS-unrelated PCNSL and in 56.2% AIDS-related cases. Notably, among
AIDS-related PCNSL, expression of BCL-6 was mutually exclusive with
expression of Epstein-Barr virus (EBV)-encoded latent
membrane protein (LMP)-1 and, with few exceptions, also of BCL-2. All
but one PCNSL expressed hMSH2, which among mature B cells selectively
stains GC B cells. These data suggest that PCNSL may be frequently
related to GC B cells and may be segregated into two major biologic
categories based on the expression pattern of BCL-6, LMP-1, and BCL-2.
BCL-6+/LMP-1 /BCL-2 PCNSL
occur both in the presence and in the absence of HIV infection and
consistently display a large noncleaved cell morphology. Conversely, BCL-6 /LMP-1+/BCL-2+ PCNSL
are restricted to HIV-infected hosts and are represented by lymphomas
with immunoblastic features. These data are relevant for the
pathogenesis and histogenesis of PCNSL and may be helpful to segregate
distinct biologic and prognostic categories of these lymphomas.
© 1998 by The American Society of Hematology.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Hassan, C. G. Stefanoff, F. Felisbino, M. H. M. Barros, I. R. Zalcberg, C. E. Klumb, R. S. Bigni, and H. N. Seuanez
Second Epstein-Barr Virus-Associated Burkitt's Lymphoma of the CNS in a Child With Progressive Renal Failure
J. Clin. Oncol.,
June 20, 2008;
26(18):
3085 - 3087.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. W. Tun, D. Personett, K. A. Baskerville, D. M. Menke, K. A. Jaeckle, P. Kreinest, B. Edenfield, A. C. Zubair, B. P. O'Neill, W. R. Lai, et al.
Pathway analysis of primary central nervous system lymphoma
Blood,
March 15, 2008;
111(6):
3200 - 3210.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Hohaus, M Giachelia, A Di Febo, M Martini, G Massini, B Vannata, F D'Alo', F Guidi, M Greco, F Pierconti, et al.
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma
Ann. Onc.,
August 1, 2007;
18(8):
1376 - 1381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Pagano, A. Gallamini, G. Trape, L. Fianchi, D. Mattei, G. Todeschini, A. Spadea, S. Cinieri, E. Iannitto, M. Martelli, et al.
NK/T-cell lymphomas 'nasal type': an Italian multicentric retrospective survey
Ann. Onc.,
May 1, 2006;
17(5):
794 - 800.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-H. Lin, K.-T. Kuo, S.-S. Chuang, S.-H. Kuo, J. H. Chang, K.-C. Chang, H.-C. Hsu, H.-F. Tien, and A.-L. Cheng
Comparison of the Expression and Prognostic Significance of Differentiation Markers between Diffuse Large B-Cell Lymphoma of Central Nervous System Origin and Peripheral Nodal Origin
Clin. Cancer Res.,
February 15, 2006;
12(4):
1152 - 1156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Camilleri-Broet, E. Criniere, P. Broet, V. Delwail, K. Mokhtari, A. Moreau, M. Kujas, M. Raphael, W. Iraqi, C. Sautes-Fridman, et al.
A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases
Blood,
January 1, 2006;
107(1):
190 - 196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Coupland, C. Loddenkemper, J. R. Smith, R. M. Braziel, F. Charlotte, I. Anagnostopoulos, and H. Stein
Expression of Immunoglobulin Transcription Factors in Primary Intraocular Lymphoma and Primary Central Nervous System Lymphoma
Invest. Ophthalmol. Vis. Sci.,
November 1, 2005;
46(11):
3957 - 3964.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Coupland, M. Hummel, H.-H. Muller, and H. Stein
Molecular Analysis of Immunoglobulin Genes in Primary Intraocular Lymphoma
Invest. Ophthalmol. Vis. Sci.,
October 1, 2005;
46(10):
3507 - 3514.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Del Valle, S. Enam, C. Lara, J. Miklossy, K. Khalili, and J. Gordon
Primary Central Nervous System Lymphoma Expressing the Human Neurotropic Polyomavirus, JC Virus, Genome
J. Virol.,
April 1, 2004;
78(7):
3462 - 3469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Montesinos-Rongen, D. Van Roost, C. Schaller, O. D. Wiestler, and M. Deckert
Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation
Blood,
March 1, 2004;
103(5):
1869 - 1875.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Thompson and R. Kurzrock
Epstein-Barr Virus and Cancer
Clin. Cancer Res.,
February 1, 2004;
10(3):
803 - 821.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J.M. Ferreri, L. E. Abrey, J.-Y. Blay, B. Borisch, J. Hochman, E. A. Neuwelt, J. Yahalom, E. Zucca, F. Cavalli, J. Armitage, et al.
Summary Statement on Primary Central Nervous System Lymphomas From the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002
J. Clin. Oncol.,
June 15, 2003;
21(12):
2407 - 2414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Baehring, D. Damek, E. C. Martin, R. A. Betensky, and F. H. Hochberg
Neurolymphomatosis
Neuro-oncol,
April 1, 2003;
5(2):
104 - 115.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Braaten, R. A. Betensky, L. de Leval, Y. Okada, F. H. Hochberg, D. N. Louis, N. L. Harris, and T. T. Batchelor
BCL-6 Expression Predicts Improved Survival in Patients with Primary Central Nervous System Lymphoma
Clin. Cancer Res.,
March 1, 2003;
9(3):
1063 - 1069.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gloghini, G. Gaidano, L. M. Larocca, F. Pierconti, A. Cingolani, L. Dal Maso, D. Capello, S. Franceschi, U. Tirelli, M. Libra, et al.
Expression of Cyclin-Dependent Kinase Inhibitor p27Kip1 in AIDS-Related Diffuse Large-Cell Lymphomas Is Associated with Epstein-Barr Virus-Encoded Latent Membrane Protein 1
Am. J. Pathol.,
July 1, 2002;
161(1):
163 - 171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Besson, A. Goubar, J. Gabarre, W. Rozenbaum, G. Pialoux, F.-P. Chatelet, C. Katlama, F. Charlotte, B. Dupont, N. Brousse, et al.
Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy
Blood,
October 15, 2001;
98(8):
2339 - 2344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. F. Israel, R. J. Pickles, D. M. Segal, R. D. Gerard, and S. C. Kenney
Enhancement of Adenovirus Vector Entry into CD70-Positive B-Cell Lines by Using a Bispecific CD70-Adenovirus Fiber Antibody
J. Virol.,
June 1, 2001;
75(11):
5215 - 5221.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. Teofili, A. L. Di Febo, F. Pierconti, N. Maggiano, M. Bendandi, S. Rutella, A. Cingolani, N. Di Renzo, P. Musto, S. Pileri, et al.
Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease
Blood,
February 15, 2001;
97(4):
1063 - 1069.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Carbone, A. Gloghini, L. M. Larocca, D. Capello, F. Pierconti, V. Canzonieri, U. Tirelli, R. Dalla-Favera, and G. Gaidano
Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas
Blood,
February 1, 2001;
97(3):
744 - 751.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Cingolani, R. Gastaldi, L. Fassone, F. Pierconti, M. L. Giancola, M. Martini, A. De Luca, A. Ammassari, C. Mazzone, E. Pescarmona, et al.
Epstein-Barr Virus Infection Is Predictive of CNS Involvement in Systemic AIDS-Related Non-Hodgkin's Lymphomas
J. Clin. Oncol.,
October 19, 2000;
18(19):
3325 - 3330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. S. Lossos and R. Levy
Mutation analysis of the 5' noncoding regulatory region of the BCL-6 gene in non-Hodgkin lymphoma: evidence for recurrent mutations and intraclonal heterogeneity
Blood,
February 15, 2000;
95(4):
1400 - 1405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Montesinos-Rongen, R. Kuppers, D. Schluter, T. Spieker, D. Van Roost, C. Schaller, G. Reifenberger, O. D. Wiestler, and M. Deckert-Schluter
Primary Central Nervous System Lymphomas Are Derived from Germinal-Center B Cells and Show a Preferential Usage of the V4-34 Gene Segment
Am. J. Pathol.,
December 1, 1999;
155(6):
2077 - 2086.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. H. Rickert, B. Dockhorn-Dworniczak, R. Simon, and W. Paulus
Chromosomal Imbalances in Primary Lymphomas of the Central Nervous System
Am. J. Pathol.,
November 1, 1999;
155(5):
1445 - 1451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Thompsett, D. W. Ellison, F. K. Stevenson, and D. Zhu
VH Gene Sequences From Primary Central Nervous System Lymphomas Indicate Derivation From Highly Mutated Germinal Center B Cells With Ongoing Mutational Activity
Blood,
September 1, 1999;
94(5):
1738 - 1746.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Carbone, A. Gloghini, L. M. Larocca, A. Antinori, B. Falini, U. Tirelli, R. Dalla-Favera, and G. Gaidano
Human Immunodeficiency Virus-Associated Hodgkin's Disease Derives From Post-Germinal Center B Cells
Blood,
April 1, 1999;
93(7):
2319 - 2326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Carbone, A. Gloghini, G. Gaidano, S. Franceschi, D. Capello, H. G. Drexler, B. Falini, and R. Dalla-Favera
Expression Status of BCL-6 and Syndecan-1 Identifies Distinct Histogenetic Subtypes of Hodgkin's Disease
Blood,
October 1, 1998;
92(7):
2220 - 2228.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |